+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Narcolepsy Treatment Market by Drug Class (Antidepressants, Orexin Receptor Agonists, Sodium Oxybate), Disorder Type (Narcolepsy Type 1, Narcolepsy Type 2), Age Group, Distribution Channel - Global Forecast 2025-2030- Product Image
Narcolepsy Treatment Market by Drug Class (Antidepressants, Orexin Receptor Agonists, Sodium Oxybate), Disorder Type (Narcolepsy Type 1, Narcolepsy Type 2), Age Group, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Narcolepsy Treatment Market by Drug Class (Antidepressants, Orexin Receptor Agonists, Sodium Oxybate), Disorder Type (Narcolepsy Type 1, Narcolepsy Type 2), Age Group, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968747
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The narcolepsy treatment market is transforming as innovative therapeutics, digital care technologies, and evolving clinical practice standards reshape patient outcomes and industry priorities. As health systems, payers, and manufacturers adapt, new collaboration and regulatory strategies are emerging to meet dynamic patient and stakeholder needs.

Market Snapshot: Narcolepsy Treatment Market Size & Growth

The narcolepsy treatment market grew from USD 2.14 billion in 2024 to USD 2.31 billion in 2025, with growth anticipated at a CAGR of 7.86%, reaching USD 3.38 billion by 2030. Market expansion is fueled by increased clinical awareness, emerging therapies targeting orexin receptors, and broader adoption of digital health tools for diagnosing and managing this complex disorder.

Scope & Segmentation

This report provides in-depth coverage of the narcolepsy treatment market, spanning therapeutic advancements, evolving patient care models, and regional market dynamics. Segment analysis is detailed as follows:

  • Drug Classes: Antidepressants, Orexin Receptor Agonists, Sodium Oxybate, Stimulants
  • Disorder Types: Narcolepsy Type 1, Narcolepsy Type 2
  • Age Groups: Adults, Geriatrics, Pediatrics
  • Distribution Channels: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
  • Geographies: Americas (including major U.S. states, Canada, Mexico, Brazil, Argentina), Europe/Middle East/Africa (major European and Gulf countries, selected African nations), Asia-Pacific (notably China, India, Japan, Australia, Southeast Asia)
  • Key Companies Profiled: AstraZeneca plc, Avadel Pharmaceuticals, Bayer AG, Boehringer Ingelheim GmbH, Cipla Limited, Eli Lilly and Company, Glenmark Pharmaceuticals Limited, Indivior plc, Jazz Pharmaceuticals plc, Johnson & Johnson Services, Inc., Lannett Company, Inc., Lupin Limited, Merck & Co., Inc., Mylan N.V. by Viartis, NLS Pharmaceutics, Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Limited

Disorder characteristics, technology utilization, and region-specific regulatory trends are explored to identify where unmet needs and opportunities exist.

Narcolepsy Treatment Market: Key Takeaways

  • Novel agents targeting orexin receptors are influencing treatment pathways and driving portfolio differentiation among both established and emerging industry players.
  • Telemedicine platforms and remote monitoring tools are increasingly central to patient engagement, improving medication adherence and aiding detection of symptom variability.
  • Clinical segmentation by drug class, patient age, and disorder subtype allows for precision medicine approaches that better align therapeutic outcomes with individual needs.
  • Collaborations between academic centers, biopharmaceutical innovators, and technology vendors are accelerating the development of differentiated therapies and adaptive trial protocols.
  • Regional regulatory frameworks and value assessment models are prompting manufacturers to balance evidence requirements with agile market approaches tailored to local conditions.

Tariff Impact: 2025 U.S. Tariff Adjustments

Upcoming 2025 tariff adjustments in the United States are prompting narcolepsy drug manufacturers to reevaluate active pharmaceutical ingredient sourcing and supply chain strategies. As many specialized drug components are imported, new tariffs could raise operational costs, encouraging companies to pursue nearshoring, stockpiling, or regional partnerships. Third-party logistics providers and contract manufacturers are adapting networks to sustain product flow, even as regulatory compliance and quality standards remain essential. Stakeholders are actively engaging policymakers to ensure patient access and affordability are prioritized within these policy shifts.

Methodology & Data Sources

This report integrates qualitative insights from clinical leaders, regulatory officers, and pharma executives with extensive secondary research, including peer-reviewed studies, trial registries, health authority data, and industry white papers. A rigorous triangulation process ensures alignment across scientific and market perspectives, reinforced by validation workshops with cross-disciplinary experts.

Why This Report Matters

  • Delivers actionable intelligence for senior decision-makers on evolving therapeutics, access barriers, and opportunities for sustainable innovation in narcolepsy care.
  • Enables benchmarking against leading competitors and market entrants, with a clear view of current product pipelines, regulatory developments, and partnership strategies.
  • Supports informed investment, R&D, and commercial planning through transparent segmentation analysis and up-to-date evaluation of market-enabling technologies.

Conclusion

The narcolepsy treatment market is moving toward precision therapeutics and digitally enhanced patient care, shaped by a collaborative and evidence-driven ecosystem. Senior leaders who embrace clinical innovation, supply resilience, and stakeholder engagement will be positioned for sustainable growth and competitive advantage.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advent of pitolisant as first histamine H3 receptor antagonist reshaping competitive dynamics in the narcolepsy market
5.2. Emergence of solriamfetol demonstrating superior efficacy in reducing excessive daytime sleepiness among narcolepsy patients
5.3. Integration of personalized telemedicine follow-up improving adherence and outcomes in narcolepsy treatment protocols
5.4. Growth of digital health platforms offering real-time symptom tracking and behavior modification for narcolepsy management
5.5. Expansion of non-stimulant pipeline compounds targeting novel neurotransmitter pathways beyond orexin receptor modulation
5.6. Strategic collaborations between pharmaceutical firms and sleep research centers accelerating narcolepsy drug development
5.7. Increasing emphasis on patient-reported outcome measures driving market access strategies for narcolepsy therapies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Narcolepsy Treatment Market, by Drug Class
8.1. Introduction
8.2. Antidepressants
8.3. Orexin Receptor Agonists
8.4. Sodium Oxybate
8.5. Stimulants
9. Narcolepsy Treatment Market, by Disorder Type
9.1. Introduction
9.2. Narcolepsy Type 1
9.3. Narcolepsy Type 2
10. Narcolepsy Treatment Market, by Age Group
10.1. Introduction
10.2. Adults
10.3. Geriatrics
10.4. Pediatrics
11. Narcolepsy Treatment Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. Americas Narcolepsy Treatment Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Narcolepsy Treatment Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Narcolepsy Treatment Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. AstraZeneca plc
15.3.2. Avadel Pharmaceuticals
15.3.3. Bayer AG
15.3.4. Boehringer Ingelheim GmbH
15.3.5. Cipla Limited
15.3.6. Eli Lilly and Company
15.3.7. Glenmark Pharmaceuticals Limited
15.3.8. Indivior plc
15.3.9. Jazz Pharmaceuticals plc
15.3.10. Johnson & Johnson Services, Inc.
15.3.11. Lannett Company, Inc.
15.3.12. Lupin Limited
15.3.13. Merck & Co., Inc.
15.3.14. Mylan N.V. by Viartis
15.3.15. NLS Pharmaceutics
15.3.16. Novartis AG
15.3.17. Pfizer Inc.
15.3.18. Sun Pharmaceutical Industries Ltd.
15.3.19. Takeda Pharmaceutical Company Limited
15.3.20. Teva Pharmaceutical Industries Limited
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. NARCOLEPSY TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. NARCOLEPSY TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. NARCOLEPSY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. NARCOLEPSY TREATMENT MARKET: RESEARCHAI
FIGURE 24. NARCOLEPSY TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 25. NARCOLEPSY TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 26. NARCOLEPSY TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NARCOLEPSY TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY OREXIN RECEPTOR AGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY OREXIN RECEPTOR AGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY SODIUM OXYBATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY SODIUM OXYBATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY STIMULANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY STIMULANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE 1, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE 1, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE 2, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE 2, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY ADULTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY GERIATRICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY PEDIATRICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 42. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 43. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 44. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 45. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 46. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 47. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 48. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 51. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 52. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 53. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 54. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 55. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 56. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 57. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 58. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 59. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 60. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 61. CANADA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 62. CANADA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 63. CANADA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 64. CANADA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 65. CANADA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 66. CANADA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 67. CANADA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 68. CANADA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 69. MEXICO NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 70. MEXICO NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 71. MEXICO NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 72. MEXICO NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 73. MEXICO NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 74. MEXICO NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 75. MEXICO NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 76. MEXICO NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 77. BRAZIL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 78. BRAZIL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 79. BRAZIL NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 80. BRAZIL NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 81. BRAZIL NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 82. BRAZIL NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 83. BRAZIL NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 84. BRAZIL NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 85. ARGENTINA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 86. ARGENTINA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 87. ARGENTINA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 88. ARGENTINA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 89. ARGENTINA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 90. ARGENTINA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 91. ARGENTINA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 92. ARGENTINA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 104. UNITED KINGDOM NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 106. UNITED KINGDOM NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 108. UNITED KINGDOM NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. UNITED KINGDOM NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. GERMANY NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 112. GERMANY NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 113. GERMANY NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 114. GERMANY NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 115. GERMANY NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 116. GERMANY NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 117. GERMANY NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. GERMANY NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. FRANCE NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 120. FRANCE NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 121. FRANCE NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 122. FRANCE NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 123. FRANCE NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 124. FRANCE NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 125. FRANCE NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. FRANCE NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. RUSSIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 128. RUSSIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 129. RUSSIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 130. RUSSIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 131. RUSSIA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 132. RUSSIA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 133. RUSSIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. RUSSIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. ITALY NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 136. ITALY NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 137. ITALY NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 138. ITALY NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 139. ITALY NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 140. ITALY NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 141. ITALY NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 142. ITALY NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 143. SPAIN NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 144. SPAIN NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 145. SPAIN NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 146. SPAIN NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 147. SPAIN NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 148. SPAIN NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 149. SPAIN NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. SPAIN NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 153. UNITED ARAB EMIRATES NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 154. UNITED ARAB EMIRATES NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 155. UNITED ARAB EMIRATES NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 156. UNITED ARAB EMIRATES NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 157. UNITED ARAB EMIRATES NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. UNITED ARAB EMIRATES NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 160. SAUDI ARABIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 162. SAUDI ARABIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 164. SAUDI ARABIA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. SAUDI ARABIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 168. SOUTH AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 170. SOUTH AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 172. SOUTH AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 173. SOUTH AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. SOUTH AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. DENMARK NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 176. DENMARK NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 177. DENMARK NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 178. DENMARK NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 179. DENMARK NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 180. DENMARK NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 181. DENMARK NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. DENMARK NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. NETHERLANDS NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 184. NETHERLANDS NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 185. NETHERLANDS NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 186. NETHERLANDS NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 187. NETHERLANDS NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 188. NETHERLANDS NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 189. NETHERLANDS NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. NETHERLANDS NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. QATAR NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 192. QATAR NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 193. QATAR NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 194. QATAR NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 195. QATAR NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 196. QATAR NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 197. QATAR NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. QATAR NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. FINLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 200. FINLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 201. FINLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 202. FINLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 203. FINLAND NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 204. FINLAND NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 205. FINLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. FINLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. SWEDEN NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 208. SWEDEN NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 209. SWEDEN NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 210. SWEDEN NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 211. SWEDEN NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 212. SWEDEN NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 213. SWEDEN NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. SWEDEN NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. NIGERIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 216. NIGERIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 217. NIGERIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 218. NIGERIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 219. NIGERIA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 220. NIGERIA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 221. NIGERIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. NIGERIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. EGYPT NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 224. EGYPT NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 225. EGYPT NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 226. EGYPT NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 227. EGYPT NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 228. EGYPT NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 229. EGYPT NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. EGYPT NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. TURKEY NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 232. TURKEY NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 233. TURKEY NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 234. TURKEY NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 235. TURKEY NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 236. TURKEY NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 237. TURKEY NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. TURKEY NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. ISRAEL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 240. ISRAEL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 241. ISRAEL NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 242. ISRAEL NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 243. ISRAEL NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 244. ISRAEL NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 245. ISRAEL NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. ISRAEL NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. NORWAY NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 248. NORWAY NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 249. NORWAY NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 250. NORWAY NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 251. NORWAY NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 252. NORWAY NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 253. NORWAY NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. NORWAY NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. POLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 256. POLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 257. POLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 258. POLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 259. POLAND NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 260. POLAND NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 261. POLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. POLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. SWITZERLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 264. SWITZERLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 265. SWITZERLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 266. SWITZERLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 267. SWITZERLAND NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 268. SWITZERLAND NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 269. SWITZERLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. SWITZERLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 272. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 274. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 276. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 277. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 280. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 281. CHINA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 282. CHINA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 283. CHINA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 284. CHINA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 285. CHINA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 286. CHINA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 287. CHINA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. CHINA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. INDIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 290. INDIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 291. INDIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 292. INDIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 293. INDIA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 294. INDIA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 295. INDIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. INDIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. JAPAN NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 298. JAPAN NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 299. JAPAN NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 300. JAPAN NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 301. JAPAN NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 302. JAPAN NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 303. JAPAN NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 304. JAPAN NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 305. AUSTRALIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 306. AUSTRALIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 307. AUSTRALIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 308. AUSTRALIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 309. AUSTRALIA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 310. AUSTRALIA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 311. AUSTRALIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 312. AUSTRALIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 313. SOUTH KOREA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 314. SOUTH KOREA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 315. SOUTH KOREA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 316. SOUTH KOREA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 317. SOUTH KOREA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 318. SOUTH KOREA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 319. SOUTH KOREA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 320. SOUTH KOREA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 321. INDONESIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 322. INDONESIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 323. INDONESIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 324. INDONESIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 325. INDONESIA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 326. INDONESIA NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 327. INDONESIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 328. INDONESIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 329. THAILAND NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 330. THAILAND NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 331. THAILAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 332. THAILAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 333. THAILAND NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 334. THAILAND NARCOLEPSY TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 335. THAILAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 336. THAILAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 337. PHILIPPINES NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 338. PHILIPPINES NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 339. PHILIPPINES NARCOLEPSY TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 340. PHILIPPINES NARCOLEPSY TREATMENT MARKET

Samples

Loading
LOADING...

Companies Mentioned

  • AstraZeneca plc
  • Avadel Pharmaceuticals
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Cipla Limited
  • Eli Lilly and Company
  • Glenmark Pharmaceuticals Limited
  • Indivior plc
  • Jazz Pharmaceuticals plc
  • Johnson & Johnson Services, Inc.
  • Lannett Company, Inc.
  • Lupin Limited
  • Merck & Co., Inc.
  • Mylan N.V. by Viartis
  • NLS Pharmaceutics
  • Novartis AG
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Limited

Table Information

Report AttributeDetails
No. of Pages186
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.31 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.38 Billion
Compound Annual Growth Rate7.8%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Narcolepsy Drugs Market by Drug Class (Amphetamine Salts, Modafinil Derivatives, Novel Agents), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Formulation, End User - Global Forecast 2025-2030 - Product Image

Narcolepsy Drugs Market by Drug Class (Amphetamine Salts, Modafinil Derivatives, Novel Agents), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Formulation, End User - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Narcolepsy Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Narcolepsy Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Sodium Oxybate Oral Medications Market by Indication (Idiopathic Hypersomnia, Narcolepsy, Off-Label Use), Strength (Four Point Five Gram, Nine Gram, Seven Point Five Gram), Distribution Channel, Dosage Form, End User, Packaging Type, Patient Age Group - Global Forecast 2025-2030 - Product Image

Sodium Oxybate Oral Medications Market by Indication (Idiopathic Hypersomnia, Narcolepsy, Off-Label Use), Strength (Four Point Five Gram, Nine Gram, Seven Point Five Gram), Distribution Channel, Dosage Form, End User, Packaging Type, Patient Age Group - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Narcolepsy Therapeutics - Global Strategic Business Report - Product Image

Narcolepsy Therapeutics - Global Strategic Business Report

  • Report
  • 363 Pages
  • Global
From
Narcolepsy Drugs Market Report by Type, Disease Type, Therapeutic Type, and Region 2025-2033 - Product Image

Narcolepsy Drugs Market Report by Type, Disease Type, Therapeutic Type, and Region 2025-2033

  • Report
  • 150 Pages
  • Global
From

About the Narcolepsy Drug Market

The Narcolepsy Drug market is a subset of the Central Nervous System Drugs market. Narcolepsy is a neurological disorder characterized by excessive daytime sleepiness and sudden, uncontrollable episodes of sleep. Narcolepsy drugs are used to reduce the symptoms of the disorder, such as excessive daytime sleepiness, cataplexy, and sleep paralysis. These drugs are typically stimulants, such as modafinil, armodafinil, and methylphenidate. Other drugs used to treat narcolepsy include tricyclic antidepressants, sodium oxybate, and clonidine. Some companies in the Narcolepsy Drug market include Cephalon, Inc., Teva Pharmaceuticals, Mylan Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.